The story of Viagra offers a complicated case study for investors eyeing the pharmaceutical sector. While initial sales were astounding, present patent expiry and the rise of cheaper versions have considerably affected earnings. Moreover, increasing regulatory scrutiny and calls to reduce prescri

The emergence of so-called "High Roller The Pill" – often referring to exceptionally high doses ordered by disreputable physicians – represents a unusually alarming trend. While common dosages of Sildenafil are intended for treating erectile dysfunction safely in most individuals, these significa